SWOG S1815

Primary Category:

Treatment Protocols

Disease Category:

Cholangiocarcinoma, Gallbladder, Gastrointestinal

Status:

Temporarily Closed

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Eligible for screening study DCP 001

NCT#03768414

Effective, March 5th, 2020, study S1815 will be temporarily closed to accrual of new patients.  Accrual will re-open after the revision for the accrual goal increase is approved and distributed.